Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol Challenge to Predict ICS Response in COPD
NCT00117182Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- Jul 2005
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Bronchitol in chronic obstructive pulmonary disease (COPD), sponsored by Syntara Limited. Started Jul 2005; status: completed.
02
Drugs
Bronchitol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00117182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117182.